Literature DB >> 29962825

Differential Response to Heart Failure Medications in Children.

Shelley D Miyamoto1, Carmen C Sucharov2, Kathleen C Woulfe2.   

Abstract

There have been many advances in the treatment of heart failure over the past several years. While these advancements have resulted in improved outcomes in adults with heart failure, these same treatments do not seem to be as efficacious in children with heart failure. Investigations of the failing pediatric heart suggest that there are unique phenotypic, pathologic and molecular differences that could influence how children with heart failure response to adult-based therapies. In this review, several recent studies and the potential implications of their findings on informing the future of the management of pediatric heart failure are discussed.

Entities:  

Keywords:  Heart Failure; children; dilated cardiomyopathy

Year:  2018        PMID： 29962825      PMCID： PMC6023416          DOI： 10.1016/j.ppedcard.2018.01.011

Source DB:  PubMed          Journal:  Prog Pediatr Cardiol        ISSN： 1058-9813


  34 in total

1.  Plasma catecholamine levels parallel severity of heart failure and have prognostic value in children with dilated cardiomyopathy.

Authors:  Poothirikovil Venugopalan; Ajit Kumar Agarwal
Journal:  Eur J Heart Fail       Date:  2003-10       Impact factor: 15.534

2.  Hemodynamic and clinical benefits with intravenous milrinone in severe chronic heart failure: results of a multicenter study in the United States.

Authors:  J L Anderson
Journal:  Am Heart J       Date:  1991-06       Impact factor: 4.749

3.  Clinical features and outcomes of childhood dilated cardiomyopathy: results from a national population-based study.

Authors:  Piers E F Daubeney; Alan W Nugent; Patty Chondros; John B Carlin; Steven D Colan; Michael Cheung; Andrew M Davis; C W Chow; Robert G Weintraub
Journal:  Circulation       Date:  2006-11-20       Impact factor: 29.690

4.  Incidence, causes, and outcomes of dilated cardiomyopathy in children.

Authors:  Jeffrey A Towbin; April M Lowe; Steven D Colan; Lynn A Sleeper; E John Orav; Sarah Clunie; Jane Messere; Gerald F Cox; Paul R Lurie; Daphne Hsu; Charles Canter; James D Wilkinson; Steven E Lipshultz
Journal:  JAMA       Date:  2006-10-18       Impact factor: 56.272

5.  Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial.

Authors:  Michael S Cuffe; Robert M Califf; Kirkwood F Adams; Raymond Benza; Robert Bourge; Wilson S Colucci; Barry M Massie; Christopher M O'Connor; Ileana Pina; Rebecca Quigg; Marc A Silver; Mihai Gheorghiade
Journal:  JAMA       Date:  2002-03-27       Impact factor: 56.272

6.  Pediatric and adult dilated cardiomyopathy represent distinct pathological entities.

Authors:  Meghna D Patel; Jayaram Mohan; Caralin Schneider; Geetika Bajpai; Enkhsaikhan Purevjav; Charles E Canter; Jeffrey Towbin; Andrea Bredemeyer; Kory J Lavine
Journal:  JCI Insight       Date:  2017-07-20

7.  Evaluation of a new bipyridine inotropic agent--milrinone--in patients with severe congestive heart failure.

Authors:  D S Baim; A V McDowell; J Cherniles; E S Monrad; J A Parker; J Edelson; E Braunwald; W Grossman
Journal:  N Engl J Med       Date:  1983-09-29       Impact factor: 91.245

8.  Cardiac Adenylyl Cyclase and Phosphodiesterase Expression Profiles Vary by Age, Disease, and Chronic Phosphodiesterase Inhibitor Treatment.

Authors:  Stephanie J Nakano; Juliana Sucharov; Robert van Dusen; Mackenzie Cecil; Karin Nunley; Sean Wickers; Anis Karimpur-Fard; Brian L Stauffer; Shelley D Miyamoto; Carmen C Sucharov
Journal:  J Card Fail       Date:  2016-07-15       Impact factor: 5.712

9.  Multicenter, double-blind study of intravenous milrinone for patients with acute heart failure in Japan. Japan Intravenous Milrinone Investigators.

Authors:  Y Seino; S Momomura; T Takano; H Hayakawa; K Katoh
Journal:  Crit Care Med       Date:  1996-09       Impact factor: 7.598

10.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.

Authors:  M Packer; M R Bristow; J N Cohn; W S Colucci; M B Fowler; E M Gilbert; N H Shusterman
Journal:  N Engl J Med       Date:  1996-05-23       Impact factor: 91.245
View more
  4 in total

Review 1.  Heart Failure with Preserved Ejection Fraction in Children.

Authors:  Bibhuti Das; Shriprasad Deshpande; Jyothsna Akam-Venkata; Divya Shakti; William Moskowitz; Steven E Lipshultz
Journal:  Pediatr Cardiol       Date:  2022-08-17       Impact factor: 1.838

Review 2.  From pediatrics to geriatrics: Mechanisms of heart failure across the life-course.

Authors:  Kathleen C Woulfe; Danielle R Bruns
Journal:  J Mol Cell Cardiol       Date:  2018-11-17       Impact factor: 5.000

Review 3.  Physiology of the Right Ventricle Across the Lifespan.

Authors:  Kathleen C Woulfe; Lori A Walker
Journal:  Front Physiol       Date:  2021-03-02       Impact factor: 4.566

4.  Serum response factor deletion 5 regulates phospholamban phosphorylation and calcium uptake.

Authors:  Kathleen C Woulfe; Danielle A Jeffrey; Julie Pires Da Silva; Cortney E Wilson; Jennifer H Mahaffey; Edward Lau; Dobromir Slavov; Frehiwet Hailu; Anis Karimpour-Fard; Karen Dockstader; Michael R Bristow; Brian L Stauffer; Shelley D Miyamoto; Carmen C Sucharov
Journal:  J Mol Cell Cardiol       Date:  2021-06-15       Impact factor: 5.763
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.